Preferred Label : Spastic paraplegia 2, X-linked;
Symbol : SPG2;
CISMeF acronym : SPG2; SPPX2;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : SPPX2;
Description : The hereditary spastic paraplegias (SPG) are a group of clinically and genetically
diverse disorders characterized by progressive, usually severe, lower extremity spasticity;
see reviews of Fink et al. (1996) and Fink (1997). Some forms of SPG are considered
'uncomplicated,' i.e., progressive spasticity occurs in isolation; others are considered
'complicated,' i.e., progressive spasticity occurs with other neurologic features.
X-linked, autosomal dominant (see 182600), and autosomal recessive (see 270800) forms
of SPG have been described. For discussion of genetic heterogeneity of X-linked SPG,
see 303350.;
Inheritance : X-linked recessive;
Molecular basis : Caused by mutation in the proteolipid protein 1 gene (PLP1, 300401.0012);
Prefixed ID : #312920;
Origin ID : 312920;
UMLS CUI : C1839264;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)